0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

History of Fixed-Dose Combination Therapy for Hypertension

James L. Wofford, MD, MS
Arch Intern Med. 1997;157(9):1044. doi:10.1001/archinte.1997.00440300166021.
Text Size: A A A
Published online

The excellent historical perspective on fixed-dose combination therapies for hypertension by Epstein and Bakris1 did not include discussion of the earliest combination medications for hypertension. Their article misstated that fixed-dose combinations have always included a diuretic as a component until the release of an angiotensin-converting enzyme inhibitor—calcium antagonist combination this year. A look even further back in history reveals the earlier existence of several nondiuretic combination medications that illustrate the very principles used to justify the resurging interest in combination antihypertensives.

Reserpine and other rauwolfia derivatives were offered in fixed-dose combination with a variety of medications during the 1950s, before diuretics were even approved for the treatment of hypertension. The combination of rauwolfia and veratrum (a parasympathomimetic agent) was marketed as Verapene, a medication that enhances antihypertensive efficacy but avoids side effects by reducing the dose of the component antihypertensives.2 In an era when anxiety and hypertension were

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();